According to IHC grouping, 69.0% of tumours showed a positive hormone receptor expression and can therefore be classified as Luminal-like subtypes, and GEP identified an intrinsic Luminal subtype (Luminal A and B) in 54.9% of BC specimens, like it has been demonstrated before [19, 43]. This evidence concerns the gene NR4A1 and breast cancer.